(19)

(11)

EP 4 322 771 A1

(12)

(43) Date of publication: 21.02.2024 Bulletin 2024/08 (21) Application number: 22788901.1 (22) Date of filing: 13.04.2022

(51) International Patent Classification (IPC):  A23L 33/135(2016.01) A23L 33/195(2016.01) A23L 33/21(2016.01) (52) Cooperative Patent Classification (CPC): A23L 33/21; A23L 33/135; A23L 33/40; A61K 9/00; A61K 45/06; A61P 43/00; A61K 31/702   C-Sets: A61K 31/702, A61K 2300/00; (86) International application number: PCT/US2022/024716 (87) International publication number: WO 2022/221477 (20.10.2022 Gazette 2022/42)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 13.04.2021 US 202163174406 P (71) Applicant: Infinant Health, Inc Davis, CA 95618 (US)	(72) Inventors: KYLE, David J. Davis, CA, California 95618 (US) MITCHELL, Ryan Davis, CA, California 95618 (US) (74) Representative: Henderson, Helen Lee  Withers & Rogers LLP 2 London Bridge London SE1 9RA London SE1 9RA (GB)